Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US14044139Application Date: 2013-10-02
-
Publication No.: US09271941B2Publication Date: 2016-03-01
- Inventor: Douglas J. DeMarini , Francisco Henriquez , Ngocdiep T. Le , Lihong Wang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Ferraro
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K31/519 ; A61K9/20 ; A61J3/06 ; A61J3/10 ; C07D471/04

Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Public/Granted literature
- US20140037726A1 NOVEL PHARMACEUTICAL COMPOSITION Public/Granted day:2014-02-06
Information query